Assay validation
Demonstrating analytical sensitivity, analytical specificity, accuracy, precision and limit of detection (LoD) for molecular assays and laboratory-developed tests.
Supporting molecular laboratories with assay validation, quality control, proficiency testing and accreditation readiness activities.
Molecular laboratory directors, technical supervisors, molecular pathologists, quality managers and senior technologists responsible for assay validation, quality control, external quality assessment and accreditation readiness.
We provide independent quality controls, clinical genomics reference materials, proficiency testing solutions and informatics tools that support assay validation, verification, quality monitoring and regulatory compliance.
Supporting molecular laboratories through validation, quality control and accreditation readiness
Molecular diagnostics uses DNA, RNA and other molecular biomarkers to detect, characterise and monitor disease using technologies such as qPCR, digital PCR and next-generation sequencing (NGS).
Most molecular assays require positive controls, negative controls, no-template controls and assay-specific quality control materials that demonstrate performance remains within established acceptance criteria.
Run controls monitor routine assay performance, whereas reference materials are used to establish or verify analytical performance characteristics such as accuracy, precision and LoD.
Validation studies commonly use characterised reference materials, contrived samples and clinical specimens to demonstrate assay performance claims.
LoD studies establish the lowest concentration at which an assay can reliably detect the target with predefined confidence.
Both assess laboratory performance using external samples. Proficiency testing is typically a formal assessment programme, while external quality assessment (EQA) may encompass broader inter-laboratory performance comparisons.
Independent quality controls, reference materials and lot comparison studies help identify changes in analytical performance following reagent or consumable changes.
Inspections typically review validation records, QC data, proficiency testing results, corrective actions, lot verification studies and quality management documentation.
Oncology assays frequently require low-frequency variant controls and sensitivity monitoring, while infectious disease assays place greater emphasis on extraction controls, amplification controls and contamination monitoring.
Yes. Independent controls and reference materials can support both validation and ongoing quality monitoring of laboratory-developed tests.
Whether you are validating a laboratory-developed test, implementing a new NGS panel, monitoring analytical performance or preparing for CAP accreditation, our specialists can help identify appropriate quality controls, reference materials and proficiency testing solutions for your molecular laboratory.